Connect With Us

Resources

Attached are the references mentioned in the Package Insert as well as on the DIPLOSOL vs. TYLENOL vs. Aleve comparison page.

PDF Resources

DIPLOSOL VS TYLENOL VS ALEVE

Gonzalez-Perez 2006: GI Bleeding occurs with paracetamol (Tylenol/acetaminophen)

Goldfine 2013: SESA lowers Hemoglobin A1c, lowers blood sugar, and lowers uric acid

Hauser 2016: SESA Safety in Cardiac Patients

Kleinman 1988: Case report of salicylate toxicity due to unintentional overdose of SESA in a hemodialysis patient

Yang 2010: Plant origin of SESA (fissigtigma cavaleriei)

Wang 1988: Sick ethyroid due to SESA

Yang 2009 Betalactamase Inhibitor

Lanza 1989: Endoscopic findings of SESA vs Naprosyn (Aleve): SESA significantly better

DIPLOSOL Package Insert

Cryer 1990: Endoscopic findings of SESA's ey as a placebo on mucosa of stomach./duodenum vs aspirin

Porro 1999: Endoscopic proof of greater safety on GI mucosa with SESA compared to the NSAID Piroxicam

Rosenkranz 1986: SESA's active moiety salicylic acid has NO effect on renal prostaglandin production nor any effect on prostacyclin production

Hauser 2016 supplement: 30 months proof of cardiac safety of SESA in coronary artery patients

REFERENCES FOR FDA

O N RE J Int Med Res, 1979

Harrison 1992: No effect of food on absorption of SESA

Cohen 1979: SESA has no risk of GI blood loss compared to a placebo

One Case report of nephrotic syndrome due to SESA

Montrone SSA vs piroxicam 1989 DB with gastroscopy